Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy

Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy

Heart failure is a major cause of morbidity and mortality worldwide. Here the authors show that subcutaneous administration of antisense oligonucleotides targeting PLN is an effective strategy in preclinical models of genetic cardiomyopathy and ischemia-driven heart failure.

Saved in:
Bibliographic Details
Main Authors: Niels Grote Beverborg, Daniela Später, Ralph Knöll, Alejandro Hidalgo, Steve T. Yeh, Zaher Elbeck, Herman H. W. Silljé, Tim R. Eijgenraam, Humam Siga, Magdalena Zurek, Malin Palmér, Susanne Pehrsson, Tamsin Albery, Nils Bomer, Martijn F. Hoes, Cornelis J. Boogerd, Michael Frisk, Eva van Rooij, Sagar Damle, William E. Louch, Qing-Dong Wang, Regina Fritsche-Danielson, Kenneth R. Chien, Kenny M. Hansson, Adam E. Mullick, Rudolf A. de Boer, Peter van der Meer
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Science
Q
Online Access:https://doaj.org/article/fe3711b0c9be44609d25d2ed5e1f2344
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/fe3711b0c9be44609d25d2ed5e1f2344

Similar Items